XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
Preferred Stock, Common Stock and Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Summary of Stock Option Activity

A summary of the Company’s stock option activity under the 2013 Plan is as follows:

 

 

 

Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term (Years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2022

 

 

491,851

 

 

$

19.11

 

 

 

7.22

 

 

 

 

Granted

 

 

153,750

 

 

$

3.07

 

 

 

9.23

 

 

 

 

Expired

 

 

(21,369

)

 

$

45.78

 

 

 

-

 

 

 

 

Outstanding at December 31, 2023

 

 

624,232

 

 

$

14.25

 

 

 

7.05

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at December 31, 2023

 

 

624,232

 

 

$

14.25

 

 

 

7.05

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at December 31, 2023

 

 

418,591

 

 

$

14.64

 

 

 

6.23

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Summary of Estimated Fair Value of Stock Option Award

The estimated fair value of each stock option award granted was determined on the date of grant using the Black Scholes option-pricing valuation model with the following assumptions for option grants during the years ended December 31, 2023 and 2022:

 

 

Year Ended December 31,

 

 

2023

 

2022

Risk free interest rate

 

1.34%-3.39%

 

1.67%-3.55%

Expected option term

 

5.5- 6.0 years

 

5.5- 6.0 years

Expected volatility of common stock

 

99.34%- 103.64%

 

97.04%- 113.23%

Expected dividend yield

 

0.0%

 

0.0%

 

 

 

 

 

 

Summary of Recognized Stock-Based Compensation Expense

The Company recognized stock-based compensation expense to employees and directors in its research and development and its general and administrative functions during the years ended December 31, 2023 and 2022 as follows:

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Research and development

 

$

2,840

 

 

$

11,278

 

Selling, general and administrative

 

 

1,125,269

 

 

 

1,447,431

 

Total stock-based compensation expense

 

$

1,128,109

 

 

$

1,458,709

 

 

 

 

 

 

 

 

Summary of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consists of the following:

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Stock options issued and outstanding

 

 

624,232

 

 

 

491,851

 

Authorized for future option grants

 

 

547,838

 

 

 

146,497

 

Authorized for employee stock purchase plan

 

 

145,381

 

 

 

37,048

 

Total common stock reserved for future issuance

 

 

1,317,451

 

 

 

675,396